CAS 849669-54-1

Hyaluronic acid sodium (MW 20 kDa)

CAS : 849669-54-1

Hyaluronic acid sodium (MW 20 kDa)

Degré de pureté : ≥95%

Ref: 54-BUP20344

AQX-016a

CAS : 849669-54-1

AQX-016a is an anticancer drug that targets the kinase protein, which plays a crucial role in the growth and proliferation of cancer cells. This drug induces apoptosis, or programmed cell death, in leukemia and other types of cancer cells by inhibiting the activity of this protein. AQX-016a has been shown to be effective in preclinical studies and is currently being evaluated for its efficacy in clinical trials. The medicinal properties of AQX-016a have been demonstrated through its ability to inhibit tumor growth and induce cell cycle arrest in Chinese hamster ovary cells. This inhibitor is excreted through urine and can be used as a potential therapeutic agent against various forms of cancer. With its potent anticancer properties, AQX-016a is a promising drug candidate for the treatment of cancer.

Formule : C₂₂H₃₂O₂

Degré de pureté : Min. 95%

Masse moléculaire : 328.5 g/mol

Ref: 3D-ZIB66954

AQX-016A

CAS : 849669-54-1

AQX-016A, a potent SHIP1 agonist, is an oral analog of pelorol, 3x stronger, inhibits PI3K, TNFa, for inflammation research.

Formule : C₂₂H₃₂O₂

Couleur et forme : Solid

Masse moléculaire : 328.49

Ref: TM-T8996